Product Images Bupropion Hydrochloride (xl)

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Bupropion Hydrochloride (xl) NDC 70518-3963 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This text appears to be the description of a medication called buPROPion HCI Extended-Release (XL) 150 mg Tablet. It suggests that the medication is available in a quantity of 30 tablets. The text also includes information about the manufacturer (ScieGen Pharmaceuticals, Inc.), the NDC number, and the lot number. The text provides a warning not to use this medication in combination with Zyban or any other medicines that contain buPROPion HCI. The directions for use are mentioned to be found in the package insert. The suggested storage temperature is between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. Lastly, it mentions that the medication has been repackaged by RemedyRepack Inc.*

MM2 - buPROPion HCl 150mg 70518 3963 01

MM2 - buPROPion HCl 150mg 70518 3963 01

Description: This is a medication called Bupropion HCI Extended-Release (XL) 150 mg Tablet. The package contains 60 tablets. It is a prescription-only drug and the NDC number is 70518-3963-01. The manufacturer is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. The medication should be kept out of the reach of children. There is a warning not to use it in combination with Zyban or any other medications that contain Bupropion HCI. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15-30°C (59-86°F) according to USP standards. It has been repackaged by Remedy Repack Inc. in Indiana, PA.*

MM3 - buPROPion HCl 150mg 70518 3963 02

MM3 - buPROPion HCl 150mg 70518 3963 02

This is a description of a medication called buPROPion HCI Extended-Release (XL) 150 mg Tablet. The package contains 90 tablets. The medication is available only with a prescription. The NDC number is 70518-3963-02. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppaugs, NY 11788. It is important to keep this medication out of reach of children. There is a warning not to use it in combination with Zyban or any other medication containing buPROPion HCI. Directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15-30°C (59-86°F). The medication has been repackaged by RemedyRepack Inc. in Indiana, PA 15701.*

bupropion hydrochloride chemical structure - bupropion hydrochloride sr 1

bupropion hydrochloride chemical structure - bupropion hydrochloride sr 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.